Cargando…
Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934582/ https://www.ncbi.nlm.nih.gov/pubmed/27417617 http://dx.doi.org/10.3390/healthcare4020029 |
_version_ | 1782441362699845632 |
---|---|
author | Huber, Elizabeth Robinson, Richard C. Noe, Carl E. Van Ness, Olivia |
author_facet | Huber, Elizabeth Robinson, Richard C. Noe, Carl E. Van Ness, Olivia |
author_sort | Huber, Elizabeth |
collection | PubMed |
description | Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence. |
format | Online Article Text |
id | pubmed-4934582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-49345822016-07-12 Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk Huber, Elizabeth Robinson, Richard C. Noe, Carl E. Van Ness, Olivia Healthcare (Basel) Review Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence. MDPI 2016-05-25 /pmc/articles/PMC4934582/ /pubmed/27417617 http://dx.doi.org/10.3390/healthcare4020029 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Huber, Elizabeth Robinson, Richard C. Noe, Carl E. Van Ness, Olivia Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title_full | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title_fullStr | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title_full_unstemmed | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title_short | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
title_sort | who benefits from chronic opioid therapy? rethinking the question of opioid misuse risk |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934582/ https://www.ncbi.nlm.nih.gov/pubmed/27417617 http://dx.doi.org/10.3390/healthcare4020029 |
work_keys_str_mv | AT huberelizabeth whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk AT robinsonrichardc whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk AT noecarle whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk AT vannessolivia whobenefitsfromchronicopioidtherapyrethinkingthequestionofopioidmisuserisk |